References
- Sutherland D. E. R. Beta-cell replacement by transplantation in diabetes mellitus: which patients at what risk, which way (when pancreas, when islets), and how to allocate deceased donor pancreases. Curr Opin Organ Transplant, 2005, 10: 147–149.
- Stock P. Beta-cell replacement for type 1 diabetes mellitus - islet versus solid organ pancreas. Curr Opin Organ Transplant, 2005, 10: 70–74.
- Boggi U., Vistoli F., DelChiaro M., Signori S., De Candio G., Amorese G., Coppelli A., Marchetti P., Mosca F. Surgical Techniques for Pancreas Transplantation. Curr Opin Organ Transplant, 2005, 10: 75–87.
- Kaufmann D., Salvalaggio P. R. O. Immunosuppression for pancreas transplantation. Curr Opin Organ Transplant, 2005, 10: 88–94.
- Robetson R. P. 2005 update: Impact of pancreas and islet transplantation on acute and chronic complications of diabetes. Curr Opin Organ Transplant, 2005, 10: 95–99.
- Sutherland D. E. R., Gruessner A., Hering J. Beta-cell replacement therapy (pancreas and islet transplantation): an integrated approach. Endocr Metab Clin N Amer, 2004, 33: 135–48.
- Sutherland D. E. R. Pancreas and islet transplant population. In: Transplantation of the Pancreas. Gruessner R. W. G., Sutherland D. E. R. (eds.). New York, Springer-Verlag, 2004, pp. 91–92.
- Matsumoto I., Sawada T., Nakano M., Sakai T., Liu B., Ansite J. D., Zhang H. J., Kandaswamy R., Sutherland D. E. R., Hering B. J. Improvements in islet yield from obese donors for human islet transplants. Transplantation, 2004, 78: 880–885.
- Nakano M., Matsumoto I., Sawada T., Ansite J., Oberbreoedkling J., Zhang H. J., Kirchof N., Shearer J., Sutherland D. E. R., Hering B. J. Capsase-3 inhibitor prevents apoptosis of human islets immediately after isolation and improves graft function. Pancreas, 2004, 29: 104–109.
- Sutherland D. E. R., Kandaswamy R., Humar A., Gruessner R. W. G. Calcineurin-inhibitor-free protocols: Use of the anti-T-cell agent Campath H-1 for maintenance immunosuppression in pancreas and pancreas/kidney recipients. Clinical Transplantation, 2004, 18 [Suppl 13]: 14–15.
- Hering B. J., Kandaswamy R., Ansite J., Eckman P. M., Nakano M., Sawada T., Matsumoto I., Ihm S.-H., Parkey J., Hunter D., Sutherland D. E. R. Single-donor, marginal-dose islet transplantation in patients with type 1 diabetes mellitus. J Am Med Assoc, 2005, 293: 830–835.
- Sutherland D. E. R., Gruessner R. W., Jie T., Nath D., Sielaff T., Dunn DL., Najarían J. S., Hering B. Pancreatic islet auto-transplantation for chronic pancreatitis. Clinical Transplantation, 2004, 18 [Suppl 13]: 17–18.
- Gruessner R. W. G., Sutherland D. E., Dunn D. L. et al. Transplant options for patients undergoing total pancreatectomy for chronic pancreatitis. J Am Coll Surg, 2004, 198: 559–567.
- Sutherland D. E., Gruessner R. W., Dunn D. L., Matas A. J., Humar A., Kandaswamy R., Mauer S. M., Kennedy W. R., Goetz F. C., Robertson R. P., Gruessner A. C., Najarían J. S. Lessons learned from more than 1,000 pancreas transplants at a single institution. Ann Surg, 2001, 233: 463–501.
- Sutherland D. E. R., Gores P. F., Farney A. C., Wahoff D. C., Matas A. J., Dunn D. L., Gruessner R. W. G., Najarían J. S. Evolution of kidney, pancreas, and islet transplantation for patients with diabetes at the university of Minnesota. Am J Surg, 1993: 166: 456–491.
- Gruessner A. C., Sutherland D. E. R. Pancreas transplant outcomes for United States (US) and non-US cases as reported to the United Network for Organ Sharing (UNOS) and the International Pancreas Transplant Registry (IPTR) as of May 2003. In: Cecka J. M., Terasaki P. I. (eds.). Clinical Transplants, 2003. Los Angeles: uCLA immunogenetics Center, 2004: 21–51.
- Venstrom J. M., McBride M. A., Rother K. I., Hirshberg B., Orchard T. J., Harlan D. M. Survival after pancreas transplantation in patients with diabetes and preserved kidney function. J Am Med Assoc, 2003, 290: 2817–2823.
- Gruessner R. W. G., Sutherland D. E. R., Gruessner A. W. Mortality Assessment in Pancreas Transplants. Am J Transplantation, 2004, 4: 2018–2026.